about
Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancerQuantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytesMyogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.KLF3 regulates muscle-specific gene expression and synergizes with serum response factor on KLF binding sitesDifferentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancerIndividual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseLarge family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.Eomesodermin is a localized maternal determinant required for endoderm induction in zebrafish.Analysis of muscle gene transcription in cultured skeletal muscle cells.Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies.Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer.Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles.Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types.Differences in the function of three conserved E-boxes of the muscle creatine kinase gene in cultured myocytes and in transgenic mouse skeletal and cardiac muscle.
P50
Q28589304-24b68eed-4ba8-a239-82a1-2e12244292b8Q28592770-9772b530-433c-ecda-8ad8-99e1ef793cedQ33602618-9f4687e1-4a6d-88f5-8f40-443542f35218Q33813779-6714afa5-4a44-e8da-a1a9-a6746e87271cQ33963844-07a40687-4eae-2775-3a05-dfe5efab400fQ35167424-cafddfb3-4728-546f-1e6b-d7d7ae057e6cQ35518696-44e9ab51-481d-30a5-249f-5c3f86e8cf85Q35608609-c9340d8e-49cc-6f1e-fc45-9bbc73a97b16Q36270733-910bbf51-4394-0eeb-f420-91610bccd859Q36675292-270b3b39-4f58-0d1b-7ac9-cbd058439666Q38320439-ddf6d487-4261-b314-63a1-0a86f274a46eQ39435013-965f8f71-4d6f-a1a8-eb60-56283441718cQ40073212-4b28c378-4074-0521-ca23-17c0fba40278Q40181522-e854c2cf-4f1a-80a8-a9dd-b469bf119af9Q42813521-50fed666-45ac-9d8a-e99b-0bbda22577c6Q44354024-5c8e62ed-4466-33d8-4147-65f767766d7aQ44461165-660fea88-4327-ea98-8da5-991739c5627bQ44580832-bd0b9bb4-415d-01f9-ab88-e6ab488b0afb
P50
description
molecular biology researcher
@en
onderzoeker
@nl
name
Charis L. Himeda
@ast
Charis L. Himeda
@en
Charis L. Himeda
@es
Charis L. Himeda
@nl
type
label
Charis L. Himeda
@ast
Charis L. Himeda
@en
Charis L. Himeda
@es
Charis L. Himeda
@nl
altLabel
Charis Himeda
@en
Charis L Himeda
@en
prefLabel
Charis L. Himeda
@ast
Charis L. Himeda
@en
Charis L. Himeda
@es
Charis L. Himeda
@nl
P106
P1153
6508345271
P2038
Charis_Himeda